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Sec34p, a Protein Required for Vesicle Tethering to the Yeast Golgi
Apparatus, Is in a Complex with Sec35p
Susan M. VanRheenen,* Xiaochun Cao,‡ Stephanie K. Sapperstein,* Elbert C. Chiang,*
Vladimir V. Lupashin,* Charles Barlowe,‡ and M. Gerard Waters*
*Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544; and ‡Department of Biochemistry,
Dartmouth Medical School, Hanover, New Hampshire 03755

Abstract. A screen for mutants of Saccharomyces cerevisiae secretory pathway components previously
yielded sec34, a mutant that accumulates numerous vesicles and fails to transport proteins from the ER to the
Golgi complex at the restrictive temperature (Wuestehube, L.J., R. Duden, A. Eun, S. Hamamoto, P. Korn, R.
Ram, and R. Schekman. 1996. Genetics. 142:393–406).
We find that SEC34 encodes a novel protein of 93-kD,
peripherally associated with membranes. The temperature-sensitive phenotype of sec34-2 is suppressed by the
rab GTPase Ypt1p that functions early in the secretory
pathway, or by the dominant form of the ER to Golgi
complex target-SNARE (soluble N-ethylmaleimide
sensitive fusion protein attachment protein receptor)–
associated protein Sly1p, Sly1-20p. Weaker suppression
is evident upon overexpression of genes encoding the
vesicle tethering factor Uso1p or the vesicle-SNAREs

Sec22p, Bet1p, or Ykt6p. This genetic suppression profile is similar to that of sec35-1, a mutant allele of a gene
encoding an ER to Golgi vesicle tethering factor and,
like Sec35p, Sec34p is required in vitro for vesicle tethering. sec34-2 and sec35-1 display a synthetic lethal interaction, a genetic result explained by the finding that
Sec34p and Sec35p can interact by two-hybrid analysis.
Fractionation of yeast cytosol indicates that Sec34p and
Sec35p exist in an z750-kD protein complex. Finally,
we describe RUD3, a novel gene identified through a
genetic screen for multicopy suppressors of a mutation
in USO1, which suppresses the sec34-2 mutation as
well.
Key words: Sec34p • Sec35p • Rud3p • vesicle tethering • secretory pathway

HE flow of material through the secretory pathway
is mediated, at least in part, by membrane-bound
vesicles or larger membrane-delimited structures
(Palade, 1975). These transport intermediates, which are
generated from numerous intracellular compartments,
dock and fuse specifically with the next membrane compartment on their itinerary. Therefore, there must be a
mechanism that allows the vesicle and target membranes
to specifically recognize one another.
For some time, members of the rab GTPase family were
suspected to be the principle determinants of this targeting
specificity because distinct family members display unique
organellar localizations that correlate with their site of action (for review see Simons and Zerial, 1993). However, it

has been demonstrated that a single chimeric rab protein
can function at two transport steps (Brennwald and Novick, 1993; Dunn et al., 1993), indicating that rabs cannot be
the sole targeting determinants. In a similar fashion,
SNAREs1 (soluble N-ethylmaleimide sensitive fusion protein attachment protein receptor) proteins, which are integral membrane proteins found predominantly on vesicles
(v-SNAREs) or target membranes (t-SNAREs), were proposed to encode specificity (Söllner et al., 1993). Once
more, however, evidence suggests that SNAREs cannot be
the only targeting components: some SNAREs can function at several transport steps in vivo (Fischer von Mollard
et al., 1997; Fischer von Mollard and Stevens, 1999),
SNAREs that faithfully function at different transport
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steps in vivo can interact promiscuously in vitro (Fasshauer et al., 1999; Yang et al., 1999), and some SNAREs
have been found in multiple SNARE complexes by coimmunoprecipitation (Lupashin et al., 1997; Holthuis et al.,
1998).
Given that neither rabs nor SNAREs are the sole governors of targeting specificity, other components are likely
to play important roles. Additional candidate players include the so-called tethering factors (Lowe et al., 1998),
which are proteins that bind membranes together before
SNARE interactions (Cao et al., 1998). Tethering factors
are a diverse group of proteins whose only common feature is their tendency to form elongated, coiled-coil structures and/or to assemble into large, multimeric complexes
(for reviews see Pfeffer, 1999; Waters and Pfeffer, 1999).
However, because they are peripheral membrane proteins, and therefore must interact with integral membrane
components with distinct localizations, once again, they
cannot be the sole determinants of targeting specificity.
Taken together, these results suggest that specificity in
vesicle traffic might be generated by the interaction of several factors in such a way that no individual component
plays the dominant role.
ER to Golgi complex traffic in the yeast Saccharomyces
cerevisiae is one of the most intensively studied steps in
membrane trafficking. The components involved in the
consumption of ER-derived vesicles at the Golgi complex are related to those of many other steps. These include: the v-SNAREs Bet1p, Bos1p, Sec22p, and perhaps
Ykt6p (Novick et al., 1980; Newman and Ferro-Novick,
1987; Dascher et al., 1991; Shim et al., 1991; McNew et
al., 1997); the t-SNARE Sed5p (Hardwick and Pelham,
1992); the t-SNARE–associated protein Sly1p (Dascher
et al., 1991); and the rab GTPase Ypt1p (Schmitt et al.,
1986). In addition to these evolutionarily conserved components, several accessory factors, which do not appear to
have sequence homologs employed at other steps within
the cell, are also required.
Two of the accessory proteins required for ER to Golgi
complex vesicle transport in yeast are Uso1p (Nakajima et
al., 1991), a homodimeric molecule with two heads and
an extraordinarily long (z150 nm) coiled-coil tail (Yamakawa et al., 1996), and Sec35p (Wuestehube et al.,
1996), a novel 32-kD protein that is present in both cytosolic and membrane-associated pools (VanRheenen et al.,
1998). Genetic studies have shown that both Uso1p (Sapperstein et al., 1996) and Sec35p (VanRheenen et al.,
1998) act upstream of the rab Ypt1p, the SNAREs, and
Sly1p. These genetic data were explained mechanistically
through the use of an in vitro system that recapitulates
transport between the ER and the Golgi complex (Barlowe, 1997). In this system, both Uso1p (Barlowe, 1997)
and Sec35p (VanRheenen et al., 1998) are required for the
stable interaction, or tethering, of ER-derived vesicles
with the Golgi complex. This Uso1p- and Sec35p-dependent tethering step precedes, and is independent of, the essential function of the SNAREs and Sly1p (Cao et al.,
1998), and suggests that tethering might occur without
trans-SNARE complex assembly.
In addition to Uso1p and Sec35p, another component
that may function in the tethering of ER-derived vesicles
is an z800-kD protein complex with ten subunits, termed
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TRAPP (Sacher et al., 1998). TRAPP is predominantly localized to the cis-Golgi complex and it is required for the
consumption of ER-derived vesicles there, which suggests
that it is involved in either tethering, SNARE-mediated
docking, or membrane fusion. Since the genetic interactions of two TRAPP genes (BET3 and BET5) with other
genes involved in ER to Golgi complex traffic are very
similar to those exhibited by USO1 and SEC35 (Rossi et al.,
1995; Jiang et al., 1998; Sacher et al., 1998), it seems likely
that TRAPP functions in the tethering process as well.
In an effort to further elucidate the mechanism of vesicle tethering, we have studied SEC34. sec34 mutants were
identified in a novel screen for secretion mutants in the
early secretory pathway of S. cerevisiae and were shown to
block ER to Golgi complex traffic concomitant with an accumulation of transport vesicles (Wuestehube et al., 1996).
In this report, we describe the cloning of SEC34 and analysis of its genetic interactions with other secretory genes.
Genetic interaction between SEC34 and other genes encoding proteins involved in ER to Golgi complex tethering
suggested that Sec34p may function in this process. Indeed, vesicle tethering was defective in an in vitro system
generated from a sec34 mutant. Interestingly, we find that
Sec34p is present in a large protein complex that contains
Sec35p. These findings indicate that the Sec34p/Sec35p
complex is a novel component required for tethering ERderived vesicles to the yeast Golgi complex and, as such,
may help to impart targeting specificity to this transport
step. Lastly, we describe a novel gene, RUD3, which was
originally identified as a high copy suppressor of a uso1
tethering mutant (Sapperstein, 1997), and which we now
find acts as a multicopy suppressor of sec34 as well. This genetic result implicates Rud3p as functioning in, or downstream of, ER to Golgi vesicle tethering.

Materials and Methods
Media and Microbial Techniques
Bacterial media was prepared by standard protocols (Miller, 1972). Yeast
strains were maintained on rich media (YPD) containing 1% Bacto-yeast
extract, 2% Bacto-peptone, and 2% glucose, or on synthetic complete media (SC) containing 0.67% yeast nitrogen base without amino acids, 2%
glucose, and the appropriate supplements (Rose et al., 1990). SC media
lacking histidine, leucine, and tryptophan used in the two-hybrid assay
contained 2.5 mM 3-aminotriazole. Diploid strains were sporulated at
room temperature in liquid media consisting of 1% potassium acetate and
0.02% glucose. Escherichia coli transformations were performed by the
method of Hanahan (1983) and yeast transformations were performed by
the method of Elble (1992), except for the yeast genomic library transformation, which was by the method of Schiestl and Gietz (1989).

Plasmid and Strain Construction
Plasmids used in this work are described in Table I. Plasmid construction
was as follows. To generate pSV22, the genomic library plasmid pB4 was
digested with PvuII and HindIII, and the resulting 2.7-kb fragment containing YER157w/SEC34 was ligated into pRS416 that had been digested
with SmaI and HindIII. To create pSV24 and pSV25, SEC34 was liberated
from the polylinker of pSV22 with either HindIII and BamHI or XhoI and
SpeI double-digests and ligated into pRS305 (digested with HindIII and
BamHI) or pRS426 (digested with XhoI and SpeI), respectively. The insert for bacterial expression plasmids encoding glutathione S-transferase
(GST)-Sec34p and His6-Sec34p fusion proteins was generated by PCR including a BamHI site adjacent to the codon for the first amino acid of
Sec34p and a SmaI site downstream of the stop codon (59 primer, 59 gccgga-tcc-atg-gcg-aga-agt-aga-aag 39; 39 primer, 59 tcc-ccc-ggg-gtt-tat-ttc-gttatg-gta-tc 39). The PCR product was digested with BamHI and SmaI, and
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ligated into similarly digested pGEX4T-1 (Pharmacia Biotech, Inc.) and
pQE30 (QIAGEN, Inc.), generating pSV28 and pSV30, respectively. To
create the constructs expressing the Gal4p DNA binding domain (Gal4pBD) or transcriptional activation domain (Gal4p-AD) fused to Sec34p,
the SEC34 open reading frame (ORF) was amplified by PCR, placing a
BamHI site upstream of the codon for the second amino acid residue of
the protein and a PstI site downstream of the stop codon (59 primer, 59
cgc-gga-tcc-tgg-cga-gaa-gta-gaa-ag 39; 39 primer, 59 cgc-gct-gca-gtt-tat-ttcgtt-atg-gta-tc 39). The resulting product was cleaved with BamHI and PstI,
and ligated into a similarly digested pAS2 or pGAD424 (Clonetech, Inc.),
yielding COOH-terminal fusions to Gal4p-BD (pSV37) and Gal4p-AD
(pSV35), respectively. The constructs expressing the Gal4p-BD or Gal4pAD fused to Sec35p were constructed in an identical manner, also placing
a BamHI site upstream of the codon for the second amino acid residue of
the protein and a PstI site downstream of the stop codon (59 primer, 59
cgc-gga-tcc-tgg-tca-aca-gtc-ata-g 39; 39 primer, 59 cgc-gct-gca-ggt-ttt-ctccca-act-atg 39), creating COOH-terminal fusions to Gal4p-BD (pSV34)
and Gal4p-AD (pSV36), respectively. To delete one copy of SEC34 in a
diploid strain by the g-method (Rose, 1995), the sec34D plasmid, pSV27,
was constructed in two stages. In the first stage, the region 59 to SEC34
was excised from plasmid pB4 as a PstI/PvuII fragment (the location of restriction enzymes sites are shown in Fig. 1 a) and ligated into PstI/SmaIdigested pRS305. In the second stage, a HindIII fragment containing the
region 39 to the locus was released from plasmid pB4 and ligated into the
plasmid generated from step one, which had been linearized with HindIII;
the correct orientation of the HindIII fragment was confirmed by restriction digest. In the resulting construct, the inserts in the polylinker of
pRS305 were placed such that the region directly 39 to the ORF was
placed upstream of the region directly 59 of the ORF, with a unique restriction site, PstI, between the two sequences; digestion of this plasmid
with PstI and transformation of the linearized plasmid into a diploid strain
results in the replacement of the coding sequences of one allele of SEC34
with the sequences of the integrating vector. To generate pSK81, ORF
YOR216c/RUD3 was isolated from the library plasmid pSOU7 (Sapperstein, 1997) as a 2.2-kb BamHI/SnaBI fragment and ligated into pRS426
that had been digested with BamHI and SmaI.
Yeast strains used in this paper are described in Table II. Strain construction was as follows. The sec34D::LEU2/SEC34 strain GWY127 was

constructed by transforming GWY30 with PstI-digested pSV27. The presence of the SEC34 deletion in the Leu1 transformants was confirmed by
PCR amplification of the novel junctions at the deletion locus. The diploid
strain heterozygous for both the sec34-2 and sec35-1 alleles was created by
mating GWY93 to GWY95 for 6 h on YPD. The diploid was identified by
the distinct morphology of the zygote, and was isolated by micromanipulation.

Cloning of SEC34
To clone SEC34, the sec34-2 strain GWY95 (Wuestehube et al., 1996;
VanRheenen et al., 1998) was transformed with a URA3 YCp50-based library (Rose et al., 1987), and temperature-resistant colonies were selected
at 38.58C. Over 100,000 transformants were screened and z90 temperature-resistant colonies were isolated. Library plasmids from nine colonies
were isolated, amplified in bacteria, and tested for the ability to confer
temperature-resistance when retransformed into the sec34-2 strain. Four
plasmids restored growth at 38.58C to wild-type levels, three yielded partial suppression, and the remaining two did not display plasmid-linked
suppression. The ends of the inserts of the seven constructs showing plasmid-linked suppression were sequenced with primers YEp24-F and
YEp24-R (Sapperstein et al., 1996) and the resulting sequences were used
to search the Saccharomyces Genome Database. To mark the YER157w
locus for purposes of integrative mapping, the sec34-2 strain GWY95 was
transformed with pSV24 that had been linearized with BglII, an enzyme
that cleaves internal to the ORF, such that integration is directed to the
YER157w locus.

Antibody Production and Immunoblotting
GST-Sec34p and His6-Sec34p were expressed in strain XL1-Blue (Stratagene) from plasmids pSV28 and pSV30, respectively, and fusion proteins
were purified according to the manufacturers’ instructions (Pharmacia
Biotech, Inc.; QIAGEN, Inc.). GST-Sec34p was used to immunize rabbits
by standard procedures (Harlow and Lane, 1988) and the resulting serum
was affinity-purified against His6-Sec34p that had been coupled to cyanogen bromide-activated Sepharose, as per the manufacturer’s instruction
(Pharmacia Biotech, Inc.). Crude yeast lysates used to characterize the af-

Table I. Plasmids Used in this Work
Plasmid

pJG103
pSFN2d
pNB167
pGR3
pSED5
pNB142
pSK47
pSK60
pSK101
pSV11
pSV17
pVA3
pTD1
pB4
pA10
pSV22
pSV24
pSV25
pSV27
pSV28
pSV30
pSV34
pSV35
pSV36
pSV37
pSOU7
pSK81

Description

Source

2mm SEC22 URA3
2mm BET1 URA3
2mm YPT1 URA3
2mm BET3 URA3
2mm SED5 URA3
2mm SEC4 URA3
2mm USO1 URA3
2mm YKT6 URA3
2mm BOS1 URA3
CEN SLY1-20 URA3
2mm SEC35 URA3
2mm Gal4p-BD-p53 TRP1
2mm Gal4p-AD-T-antigen LEU2
CEN SEC34 URA3 (library plasmid)
CEN SEC34 URA3 (library plasmid)
CEN SEC34 URA3
YIp SEC34 LEU2
2mm SEC34 URA3
YIp sec34D-construct LEU2
GST-Sec34p
His6-Sec34p
2mm Gal4p-BD-Sec35p TRP1
2mm Gal4p-AD-Sec34p LEU2
2mm Gal4p-AD-Sec35p LEU2
2mm Gal4p-BD-Sec34p TRP1
2mm RUD3 URA3 (library plasmid)
2mm RUD3 URA3

S. Ferro-Novick (Yale University, New Haven, CT)
S. Ferro-Novick
S. Ferro-Novick
S. Ferro-Novick
H. Pelham (MRC, Cambridge, UK)
P. Novick (Yale University, New Haven, CT)
This laboratory
This laboratory
This laboratory
This laboratory
This laboratory
Clonetech, Inc.
Clonetech, Inc.
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
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Table II. Strains Used in this Work
Strain

Genotype

Source

RSY255

MATa ura3-52 leu2-3,-112

RSY942
RSY944
RSY976
RSY1074
RSY1157
SFNY314

MATa sec22-3 ura3-52 lys2-801
MATa bet1-1 ura3-52 lys2-801
MATa ypt1-3 ura3-52
MATa sly1ts ura3-1 leu2-3,-112 trp1 ade2-1
MATa pep4::HIS3 prb::HisG prc::HisG ura3-1 leu2-3,112 trp1-1 ade2-1 can1-100
MATa bet3-1 ura3-52 leu2-3,-112

PJ69-4A

MATa ura3-52 leu2-3,112 trp1-901 his3-200 gal4D gal80D LYS2::GAL1-HIS3
GAL2-ADE2 met2::GAL7-lacZ
MATa/a ura3-52/ura3-52 leu2D1/leu2D1 trp1D63/trp1D63
MATa uso1-1 ura3-52 leu2-3,-112
MATa sec35-1 ura3-52 leu2-3,-112
MATa sec34-2 ura3-52 leu2-3,-112 lys2-801
MATa/a sec34D::LEU2/SEC34 ura3-52/ura3-52 leu2D1/leu2D1 trp1D63/trp1D63
MATa sec34D::LEU2 ura3-52 leu2D1 trp1D63 1pSV11 (pSLY1-20 CEN URA3)
MATa sec32-1 (bos1ts) ura3-52 his4-612 lys2-801

GWY30
GWY67
GWY93
GWY95
GWY127
GWY132
GWY138

finity-purified antibody were made as described (Ohashi et al., 1982), and
the equivalent of 0.2 OD units of cells was analyzed for each strain. HRPconjugated secondary antibodies were used at a dilution of 1:3,000. Incubations with both primary and secondary antibodies were for 1 h at room
temperature and immunoblots were developed with a chemiluminescent
detection kit (Amersham Corp.).

Extraction and Subcellular Fractionation
A 250-ml culture of wild-type yeast (RSY255) was grown in YPD at 308C
to midlogarithmic phase (OD595 5 1.4), washed in sterile water, and resuspended at z75 OD595/ml in Buffer 88 (25 mM Hepes, pH 7.0, 150 mM
KOAc, 5 mM MgCl2, 1 mM DTT) containing protease inhibitors (VanRheenen et al., 1998). 1/2 sample vol of acid-washed glass beads (425–
600 mm; Sigma Chemical Co.) was added, and the material was vortexed
eight times for 30 s, with 30 s on ice between each burst. The crude yeast
lysate was centrifuged at 1,500 g (SA600 rotor, 3,300 rpm, 3 min, 48C) to
generate the S1 lysate. For extraction studies, yeast membranes were isolated on a step gradient in which 2 ml of S1 was layered over a step gradient consisting of 2 ml of 45% sucrose and 8 ml of 10% sucrose, both in
Buffer 88. After centrifugation at 200,000 g (SW40 rotor, 40,000 rpm, 2 h,
48C), membranes were collected from the 10%/45% sucrose interface by
piercing the side of the tube with an 18 gauge needle and aspiration of the
interface. The membranes (100 ml per reaction) were then mixed with an
equal volume of Buffer 88 or a 23 extraction buffer (either 2% Triton
X-100 in Buffer 88, 2 M NaCl in Buffer 88, or 0.2 M Na2CO3, pH 11.5, in
water), diluted to 1 ml in Buffer 88 or 13 extraction buffer (either 1% Triton X-100 in Buffer 88, 1 M NaCl in Buffer 88, or 0.1 M Na2CO3, pH 11.5,
in water), and incubated on ice for 45 min. The extraction mixtures (800
ml) were then layered over 200 ml 14% sucrose cushions made in the appropriate 13 extraction buffer and centrifuged at 175,000 g (TLA100.2 rotor, 70,000 rpm, 60 min, 48C). 900 ml of the supernatant was removed from
each sample, and 800 mL of Buffer 88 was added to the pellets (in the remaining 100 ml), which were resuspended with a Dounce homogenizer.
Fractions were probed with antibodies against Sec34p, Sec35p (VanRheenen et al., 1998), Sed5p (Lupashin et al., 1997), or phosphoglycerate
kinase (PGK; Molecular Probes). Subcellular fractionation was completed
as previously described (VanRheenen et al., 1998).

R. Schekman (University of California at
Berkeley, Berkeley, CA)
R. Schekman
R. Schekman
R. Schekman
R. Schekman
S. Ferro-Novick (Yale University,
New Haven, CT)
P. James (University of
Wisconsin, Madison, WI)
This laboratory
This laboratory
This laboratory
This laboratory
This study
This study
This laboratory

ing assays, vesicles that bud from the ER by the addition of COPII components are freely diffusible and remain in the supernatant fraction after
centrifugation at 14,000 rpm; protease-protected glycosylated 35S-proa-factor (35S-gp-a-factor) contained in these vesicles was quantified after solubilization of membranes and precipitation with Concanavalin
A–Sepharose. For transport assays, COPII proteins, in addition to purified Uso1p and LMA1, were added as indicated in the figure legends, and
the amount of Golgi complex-modified 35S-gp-a-factor was measured by
immunoprecipitation with anti-a1,6-mannose–specific antibodies. The
data presented is the average of duplicate determinations and the error
bars represent the range.

Partial Purification of the Sec34p/Sec35p Complex

Yeast semi-intact cells from either the wild-type (RSY255) or the sec34-2
strain (GWY95) were prepared from logarithmic phase cultures of strains
grown at 238C and were stored at 2708C (Baker et al., 1988). Before assays, an aliquot of cells was quickly thawed and washed in Buffer 88 to remove cytosol, and 35S-pre-pro-a-factor was posttranslationally translocated into the ER of the semi-intact cells as previously described (Baker
et al., 1988). Vesicle tethering and transport assays were performed at either 23 or 298C, as indicated (Barlowe, 1997; Cao et al., 1998). For tether-

The protease deficient RSY1157 strain was grown to late log phase
(OD600 5 3.4) in 36 liters of YPD at 308C, after which all manipulations
were performed at 0–48C. The cells were harvested by centrifugation and
washed twice with water. The 334 g cell pellet was resuspended in 1 liter of
25 mM Tris-Cl, pH 8.0, 1 M KCl, 2 mM EGTA (lysis buffer) with protease
inhibitors [0.5 mM 1:10 phenanthroline, 2 mM pepstatin A, 2 mg/ml aprotinin, 0.5 mg/ml leupeptin, 1 mM PMSF, 200 mM 4-(2-aminoethyl)-benzenesulfonyl fluoride (AEBSF)] and 1 mM DTT, and lysed in an EmulsiFlex-C5 (Avestin Inc.) at 18,000–20,000 psi. The lysate was centrifuged at
5,000 g (Sorvall SLA3000 rotor, 6,000 rpm, 10 min), and the supernatant
(1.04 liter) was collected and centrifuged at 20,000 g (Sorvall SA600 rotor,
12,000 rpm, 20 min). The supernatant (960 ml) was removed, avoiding the
loose pellet, and centrifuged at 175,000 g (Beckman 45Ti rotor, 44,000
rpm, 120 min). The supernatant (S175; 750 ml at 7.3 mg protein/ml) was
removed, avoiding the pellets. The S175 was made 1 mM in EDTA, and
(NH4)2SO4 was added to 35% saturation, dissolved, and the solution was
stirred for 60 min. The (NH4)2SO4 precipitate was collected by centrifugation at 17,000 g (SLA3000 rotor, 10,000 rpm, 10 min), resuspended in
enough 25 mM Tris-Cl, pH 8.0, 1 mM DTT to yield a conductivity equivalent to that of 25 mM Tris-Cl, pH 8.0, 100 mM KCl, 1 mM DTT (T8.0/
100K/D). This material (1.55 g protein in 368 ml; 4.2 mg/ml) was loaded at
2 ml/min onto a 50 ml DEAE-Sepharose Fast Flow (Pharmacia Biotech, Inc.) column (2.5 cm i.d.) that had been equilibrated in T8.0/100K/D.
The column was washed with 200 ml of T8.0/100K/D and eluted with a linear gradient (2 mM/ml) from T8.0/100K/D to T8.0/400K/D, collecting 10
ml fractions throughout. At this and each subsequent chromatographic
step, fractions were analyzed for Sec34p and Sec35p content by immunoblotting. The fractions containing Sec34p and Sec35p, which eluted together at z160 mM KCl, were pooled (348 mg protein in 60 ml, 5.8 mg/ml).
A 200 ml aliquot of this DEAE pool was chromatographed on a 24 ml Superose 6 (HR10/30 Pharmacia Biotech, Inc.) size exclusion column equilibrated in T8.0/150K/D at 0.3 ml/min, collecting 1 ml fractions. The remaining 60 ml of the DEAE pool was then concentrated to a volume of
17.8 ml (284 mg protein at 16 mg/ml) in an Amicon 8050 Ultrafiltration
Cell (Millipore Inc.) with a YM100 (MWCO 100 kD) ultrafiltration mem-
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brane. The concentrated sample was loaded onto a 700 ml Sephacryl
S-300 (Pharmacia Biotech, Inc.) column (2.5 cm i.d.) that had been equilibrated in 25 mM Tris-Cl, pH 7.6, 100 mM KCl, 1 mM DTT (T7.6/100K/D)
and chromatographed at 1.5 ml/min in T7.6/100K/D, collecting 10 ml fractions. The fractions containing both Sec34p and Sec35p were pooled (66
mg protein in 47 ml, 1.4 mg/ml) and loaded onto an 8 ml MonoQ (HR 10/
10, Pharmacia Biotech, Inc.) anion exchange column equilibrated in T7.6/
100K/D at 1.5 ml/min. The column was washed with 36 ml of T7.6/100K/D
and eluted with a linear gradient (2.5 mM/ml) from T7.6/100K/D to
T7.6/500K/D, collecting 5 ml fractions. The fractions containing both
Sec34p and Sec35p, which coeluted at z295 mM KCl, were pooled (16 mg
protein in 18 ml, 0.89 mg/ml), dialyzed against 40 mM potassium phosphate, pH 6.8, 0 mM KCl, 1 mM DTT (KP/0K/D), and loaded onto a
MonoS (HR 5/5, Pharmacia Biotech, Inc.) equilibrated in KP/0K/D at 0.5
ml/min. The column was washed with 4 ml of KP/0K/D and eluted with a
linear KCl gradient (10 mM/ml) from KP/0K/D to KP/500K/D, collecting
2 ml fractions throughout. The fractions containing both Sec34p and
Sec35p, which coeluted at z110 mM KCl, were pooled (1.5 mg protein in
8 ml, 0.19 mg/ml) and concentrated to a volume of 0.1 ml at 9.3 mg/ml with
an Ultrafree BIOMAX centrifugal device (Millipore Inc.). The concentrated sample was loaded onto a 24 ml Superose 6 (HR10/30, Pharmacia
Biotech, Inc.) size exclusion column that had been equilibrated in T7.6/
200K/D, and chromatographed at 0.3 ml/min, collecting 0.5 ml fractions.
After this point, protein concentration was no longer determined, to not
decrease yield. The fractions containing Sec34p and Sec35p were pooled
and loaded onto a Bio-Scale CHT2-I Hydroxyapatite column (Bio-Rad
Laboratories). The column was washed with 8 ml 25 mM Tris-Cl, pH 8.0,
200 mM KCl, 0 mM potassium phosphate, 1 mM DTT (T7.6/200K/0Pi/D),
and eluted with a linear potassium phosphate gradient (16.6 mM/ml) from
T7.6/200K/0Pi/D to T7.6/200K/250Pi/D; Sec34p and Sec35p coeluted at
z100 mM potassium phosphate.

Results
Cloning of SEC34

Figure 1. The SEC34 genomic locus and the sequence of Sec34p.
a, Diagrammatic representation of a 10-kb region of the right
arm of chromosome V containing BEM2, YER156c, YER157w,
and YER158c. Relevant restriction enzyme sites (see Materials
and Methods) are indicated. b and c, Genomic fragments contained in library plasmids pB4 and pA10, respectively. d, The 2.6-kb
PvuII/HindIII fragment that contains YER157w and restores
temperature resistance to the sec34-2 strain. e, Representation of
the SEC34 (YER157w) locus in the sec34D strain, in which the
region between PvuII and HindIII is replaced by sequences in
the LEU2 integrating vector. f, Predicted amino acid sequence of
Sec34p. The nucleotide accession number for SEC34 is U18917
and the protein accession number is S50660.

To clone SEC34, the sec34-2 strain was transformed with a
low-copy (centromere, CEN) yeast genomic library and
temperature-resistant colonies were selected at 38.58C. Library plasmids were isolated from these colonies and retested for their ability to confer growth at 38.58C. Four restored growth at the restrictive temperature to wild-type
levels, and the remaining three yielded partial suppression. The ends of the inserts of the seven library plasmids
were sequenced and found to contain overlapping regions
of the right arm of chromosome V, a portion of which is
shown in Fig. 1 a. The only complete ORF contained on
each of the plasmids that conferred strong suppression of
the temperature-sensitive phenotype (two of which are
shown in Fig. 1, b and c) was YER157w. Interestingly, the
three plasmids that partially suppress the sec34-2 mutation
contained identical inserts in which only the 59 end of
YER157w is present; the inability of these plasmids to
fully suppress may be due to the absence of the COOHterminal portion of the protein. The ORF YER157w was
isolated from the genomic insert (as shown in Fig. 1 d) and
transferred to a low-copy plasmid. This construct was
demonstrated to suppress the temperature sensitivity of
the sec34-2 strain, confirming that YER157w is responsible for the suppression conferred by each of the library
plasmids. To address the possibility that YER157w was a
suppressor of the sec34-2 mutation rather than the gene itself, integrative mapping was performed. A sec34-2 strain
in which the YER157w locus was marked with LEU2 was
constructed and subsequently mated to a wild-type strain.
The resulting diploid strain was subjected to tetrad analysis and, of 38 tetrads examined, the temperature-sensi-

tive phenotype did not segregate away from the marked
locus. Thus, integrative mapping strongly suggests that
YER157w is SEC34.
SEC34 is predicted to encode an 801-amino acid protein
(Fig. 1 f) with a molecular weight of 92.5 kD and a pI of
5.2. Sec34p lacks a signal sequence, as well as transmembrane domains or other motifs that could facilitate membrane attachment. Therefore, the protein is predicted to
be either cytoplasmic or peripherally associated with
membranes. Three putative orthologs of Sec34p have been
detected. First, the C. elegans genome encodes a protein
designated Y71F9A 290.A that is 25% identical and 35%
similar to Sec34p. This 428-amino acid protein is z50%
the size of Sec34p and is homologous to the NH2 terminus
of Sec34p (spanning amino acid residues 111 to 459). Due
to the disparity in size, it is unclear whether this protein is
indeed an ortholog of Sec34p. Second, the genome of the
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fission yeast Schizosaccharomyces pombe contains a 735amino acid protein (GenBank/EMBL/DDBJ accession
number CAB51337, PID g5579050) that is 26% identical and 40% similar to Sec34p. Finally, several overlapping human expressed sequence tags (ESTs; GenBank/
EMBL/DDBJ accession numbers AA280321, AA603511,
AA429818, and z21241) have been isolated that show high
similarity to Sec34p. Sequencing of clones containing the
first two ESTs (provided by Genome Systems, Inc., St.
Louis, MO) allowed us to analyze additional sequences previously unavailable in GenBank (data not shown). By combining our newly sequenced regions with the overlapping
ESTs in the database, we obtained a 263-amino acid portion
of the putative human protein. Comparison of this partial
protein to Sec34p using the BLAST algorithm (Altschul et
al., 1990) revealed a 175-amino acid region of homology
(encompassing amino acids 531 to 706 of Sec34p) between
the human sequence and Sec34p. Within this region the two
proteins are 25% identical and 50% similar. Since the 86amino acid region 59 to this homologous region does not
display a high degree of similarity to Sec34p, the protein encoded by these ESTs may not be a true Sec34p homolog,
but instead may contain a Sec34p-like domain.

Figure 2. Deletion of SEC34
leads to a severe growth defect that can be suppressed
by expression of YPT1 or
SLY1-20. Left, The sec34D/
SEC34
diploid
strain
(GWY127) was sporulated,
dissected, and incubated on
YPD at 308C for six days.
Ten representative tetrads
are shown, each of which displays a 21:22 segregation for
size of colony. The small segregants in each tetrad are
Leu1, indicating the presence of the SEC34 deletion. Right, The growth defect of the
sec34D strain is complemented by SEC34 and suppressed by expression of YPT1 or SLY1-20. The sec34D/SEC34 diploid strain
(GWY127) or containing plasmids pSEC34 (pSV22), pYPT12mm (pNB167), or pSLY1-20 (pSV11) was sporulated and subjected to tetrad analysis. Tetrads were incubated on YPD for six
days at 308C and two representative tetrads are shown for each.

Previous analysis of the sec34 mutant strain indicated a
role for Sec34p in the docking or fusion of ER-derived
vesicles with the cis-Golgi complex (Wuestehube et al.,
1996). By testing whether SEC34 displayed genetic interactions with other factors required at this stage, as well as
at other stages of transport, we sought to confirm this assignment and to further explore the function of Sec34p.
We thus tested whether the temperature-sensitive growth
defect of the sec34-2 strain could be suppressed by overexpression of other genes required for transport. Two of the
best suppressors were found to encode the rab protein
Ypt1p and the dominant allele of the t-SNARE–associ-

ated protein, SLY1, termed SLY1-20 (Fig. 3). Although
neither gene could restore growth to the levels observed
when the strain was complemented by SEC34 on a plasmid, both conferred a significant growth advantage to the
mutant strain. A second gene, USO1, which encodes a
tethering factor, also suppressed the temperature sensitivity, but to a lesser extent than either YPT1 or SLY1-20.
Weak suppression was also observed upon overexpression of the v-SNAREs Sec22p, Bet1p, and Ykt6p, each of
which has been implicated in the ER to Golgi complex
stage of transport; no suppression was seen for another
v-SNARE involved at this step, Bos1p (Fig. 3).
Several other genes were tested for their ability to suppress the sec34-2 mutation when overexpressed, but were
found to have no effect. These genes encode the tethering
factor Sec35p, the TRAPP complex component Bet3p, the
cis-Golgi complex t-SNARE Sed5p, and the Golgi complex to plasma membrane rab protein Sec4p. The lack of
suppression by the Golgi complex to plasma membrane
rab indicates that suppression by the ER to Golgi complex
rab is specific.
We also tested whether overexpression of SEC34 could
suppress temperature-sensitive mutant alleles of several
ER to Golgi complex docking factors. Interestingly, overexpression of SEC34 was capable of weakly suppressing
the temperature-sensitive growth defect of the sec35-1
strain (data not shown). However, multicopy SEC34 was
unable to suppress mutant alleles of all other secretory
factors tested, including: the v-SNAREs Sec22p, Bos1p,
and Bet1p; the t-SNARE Sed5p; the tethering factor
Uso1p; the rab Ypt1p; and the TRAPP complex component Bet3p (data not shown). Therefore, overexpression
of either SEC34 or SEC35 (VanRheenen et al., 1998) is
unable to suppress the temperature-sensitive growth defects of the majority of tethering and docking factors, yet
multicopy SEC34 can improve the growth defect of a compromised allele of SEC35, and thus the two genes show a
genetic interaction.
Since YPT1 and SLY1-20 were efficient suppressors of
the temperature-sensitive growth defect of the sec34-2
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The SEC34 Deletion Strain Displays a Severe
Growth Defect
To evaluate the phenotype of a strain lacking SEC34, we
constructed a diploid strain in which one allele of SEC34
had been deleted (as diagrammed in Fig. 1 e) and replaced
with the gene LEU2. This strain (sec34D::LEU2/SEC34)
was sporulated and dissected, and the resulting tetrads
were incubated on rich media at 308C. As shown in Fig. 2
(left), a clear 21:22 segregation pattern was observed in
which each tetrad contained two large and two very small
colonies. The large colonies were without exception Leu2
and thus contained the wild-type copy of the gene, while
the small colonies were Leu1, indicating the presence of
the sec34D locus. Therefore, although SEC34 is not an essential gene, haploid strains lacking SEC34 are at an extreme growth disadvantage. The growth defect of the
sec34D strain is complemented by a plasmid bearing
SEC34 since the presence of the construct in the diploid
sec34D/SEC34 strain resulted in the restoration of a 41:02
segregation pattern (Fig. 2, right). In each tetrad, two segregants were Leu1 and Ura1, indicating the presence of
both the deletion and the plasmid bearing SEC34, respectively.

Genetic Analysis of SEC34

Figure 3. Suppression of the
temperature-sensitive growth
defect of the sec34-2 strain.
Tenfold serial dilutions of a
wild-type strain (RSY255)
or
the
sec34-2
strain
(GWY95) alone (---) or containing the indicated plasmids:
pSEC34
(pSV22),
pYPT1-2mm
(pNB167),
pSLY1-20 (pSV11), pRUD32mm (pSK81), pUSO1-2mm
(pSK47),
pSEC22-2mm
(pJG103),
pBET1-2mm
(pSFN2),
pYKT6-2mm
(pSK60),
pBOS1-2mm
(pSK101),
or
vector
(pRS426) were spotted onto
YPD plates and incubated at
38.58C for three days.

strain, we explored whether they could also improve the
severe growth defect of the sec34D strain. The sec34D/
SEC34 diploid strain was therefore transformed with
plasmids expressing either multicopy YPT1 or low-copy
SLY1-20, and the resulting diploids were sporulated and
subjected to tetrad analysis. Indeed, the presence of either
plasmid significantly improved the growth of the sec34D
strain (Fig. 2, right). This result implies that Ypt1p and
Sly1p most likely function downstream of, or in a parallel
pathway with, Sec34p.

Isolation of RUD3 and its Genetic Interactions with
SEC34 and USO1

searches revealed a single putative homolog of Rud3p in
the genome of S. pombe. This 401-amino acid protein
(GenBank/EMBL/DDBJ accession number AL022117,
PID g2959373) shares 28% identity and 41% similarity
with Rud3p, and thus encodes a Rud3p ortholog that we
designate spRud3p. Interestingly, spRud3p also contains a
region predicted to form a coiled-coil secondary structure,
although the homology between the proteins is not restricted to this motif. Indeed, the COOH termini of the
proteins (ranging from amino acid 365 to 484 for Rud3p,
and 280 to 401 for spRud3p) are most homologous, displaying 49% identity and 62% similarity.
To test whether Rud3p is encoded by an essential gene,
a diploid strain was created in which one of the alleles of
RUD3 was deleted and marked with LEU2. Sporulation
and tetrad dissection of this strain yielded tetrads with
four viable spores, two of which were Leu1. Upon incubation at 25, 30, and 378C, the haploid rud3D strain did not
display a significant growth defect as compared with a
wild-type strain (data not shown), and thus RUD3 is not
an essential gene.

Suppression of the sec34-2 temperature-sensitive growth
defect was also observed upon overexpression of a gene
designated RUD3 (Fig. 3). RUD3 was isolated previously
in our lab through a screen for genes that, when overexpressed, are able to suppress the temperature-sensitive
growth defect of the uso1-1 strain (Sapperstein et al., 1996;
Sapperstein, 1997). From a panel of multicopy suppressors, four library plasmids were isolated that contain overlapping regions of chromosome XV that include two hypothetical ORFs and one known gene. The suppressing
activity was localized to the hypothetical ORF YOR216c,
and this gene was named RUD3 because it relieves the
uso1-1 transport defect. RUD3 is an efficient suppressor of
the uso1-1 deficiency at 37.58C, suppressing the growth defect (Fig. 4 a), as well as the ER to Golgi complex transport block, as monitored through movement of the marker
protein, carboxypeptidase Y (data not shown).
RUD3 is predicted to encode a 484-amino acid protein
with a molecular mass of 56.1 kD and a pI of 4.67 (Fig. 4
b). Like Sec34p, this protein lacks any motifs to indicate a
localization other than cytosolic. Both the PAIRCOIL and
COILS programs (Lupas et al., 1991; Berger et al., 1995)
indicate a high probability that the protein assumes a
coiled-coil secondary structure in a central, z215-amino
acid stretch (Fig. 4, b and c). There is a region near the
center of this coiled-coil domain, however, that has a decreased coiled-coil probability; this region could potentially be a hinge in the protein (Lupas, 1996). BLAST

To analyze the Sec34 protein, we generated affinity-purified anti-Sec34p antibody. The antibody recognizes two
proteins in crude yeast extracts, the larger of which corresponds to the predicted molecular weight of Sec34p (Fig. 5
a). This protein is absent in a sec34D strain (which expressed SLY1-20 to enhance its propagation) and is overexpressed in a strain containing SEC34 on a multicopy
plasmid, and thus represents Sec34p. The smaller protein,
which is recognized despite the affinity purification, is not
related to the Sec34p locus since it is present in the sec34D
strain and its expression level is unaffected by overexpression of SEC34.
With this antibody, we investigated whether Sec34p was
capable of associating with membranes, as might be expected for a protein involved in secretion. A crude yeast
extract (designated S1) was centrifuged at 175,000 g to
separate the organelles of the secretory pathway, which
are found in the pellet fraction, from cytosolic proteins,
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Sec34p Is a Peripheral Membrane Protein

Figure 4. Genetic interaction of USO1 and RUD3 and the predicted sequence of Rud3p. a, Suppression of the temperaturesensitive growth defect of the uso1-1 strain by overexpression of
RUD3. The wild-type strain (RSY255) and the uso1-1 strain
(GWY67), either alone (---) or containing the indicated plasmids:
pUSO1-2mm (pSK47), pRUD3-2mm (pSK81), or vector
(pRS426) were treated as described in Fig. 3, except that the
strains were incubated at 37.58C for two days. b, Predicted amino
acid sequence of Rud3p with the two regions predicted to form a
coiled-coil underlined. The nucleotide accession number for
RUD3 is Z75124 and the protein accession number is S60943. c,
Probability of a coiled-coil structure for Rud3p, as predicted by
the PAIRCOIL program (Berger et al., 1995).

which are contained in the supernatant fraction. As shown
in Fig. 5 b (left), the majority of Sec34p is found in the pellet fraction, along with the integral membrane protein
Sed5p, while a small amount of Sec34p is contained in the
supernatant, as is the cytosolic marker, PGK. This result is
consistent with a peripheral membrane association for
Sec34p. To explore the basis for the sedimentation of
Sec34p, we attempted to extract the protein from an enriched membrane fraction using buffers containing Triton
X-100, NaCl, or Na2CO3, pH 11.5. As expected for an integral membrane protein, Sed5p was released into the supernatant fraction after incubation with buffer containing Triton X-100, but not after treatment with salt or high pH,
whereas the peripheral membrane protein Sec35p was released, at least partially, upon incubation with all three
buffers. Sec34p was partially shifted into the supernatant
fraction upon treatment with Triton X-100, salt, or high
pH, and thus behaves as a peripheral membrane protein
(Fig. 5 c).
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Figure 5. Biochemical characterization of Sec34p. a, Characterization of the anti-Sec34p antibody. Affinity-purified polyclonal
antibodies against Sec34p were used to probe yeast lysate (derived from 0.2 OD units of cells per lane) from either a wild-type
strain (RSY255), the sec34D strain expressing SLY1-20 to assist
growth (GWY132), or a wild-type strain overexpressing SEC34
from a multicopy plasmid (RSY255 containing pSV25). Lysates
were separated by SDS-7%PAGE and immunoblotted with affinity-purified antibody against Sec34p. The migration of molecular weight markers is indicated on the left. b, Subcellular fractionation of Sec34p. Left, Lysate (S1) from a wild-type strain
(RSY255) was centrifuged at 175,000 g and separated into pellet
(P) and supernatant (S) fractions. Right, S1 lysate was centrifuged at 10,000 g and separated into P10 and S10 fractions, and
the S10 was further centrifuged at 175,000 g and separated into
P175 and S175 fractions. c, Sec34p encodes a peripheral membrane protein. Isolated yeast membranes from a wild-type strain
(RSY255) were incubated with buffer, 1% Triton X-100, 1 M
NaCl, or 0.1 M Na2CO3, pH 11.5, as indicated, before centrifugation at 175,000 g and separation into pellet (P) and supernatant
(S) fractions. b and c, Equivalent amounts (relative to the starting material) of each fraction were separated by SDS-12%PAGE
and analyzed by immunoblotting with affinity-purified antibodies
against Sec34p (only the upper, Sec34p-specific band is shown),
Sec35p, Sed5p, and PGK, as indicated.

To further analyze the membrane association of Sec34p,
differential centrifugation was employed. The S1 fraction
was centrifuged at 10,000 g, separated into supernatant
(S10) and pellet (P10) fractions, and the S10 fraction was
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further centrifuged at 175,000 g and separated into supernatant (S175) and pellet (P175) fractions. Under these
conditions, the ER is contained primarily into the P10
fraction (data not shown), the Golgi complex partitions
between the P10 and P175 fractions, as seen with the Golgi
protein Sed5p, and cytosolic proteins remain in the supernatant fractions, as observed for PGK (Fig. 5 b, right). The
soluble portion of Sec34p is found in the S175 fraction,
while the membrane-associated pool partitions between
the P10 and P175, similar to the Golgi complex protein
Sed5p. The fractionation pattern of Sec34p is quite similar
to that observed for the peripheral membrane protein
Sec35p, although Sec34p appears to have a greater proportion of the protein in the membrane fractions.

Sec34p Is Required for Tethering of ER-derived Vesicles
to the cis-Golgi Complex
Because the mutant phenotype (Wuestehube et al., 1996)
and suppression profile of sec34-2 is similar to that of
other factors required for the tethering stage of ER to
Golgi complex transport, we investigated whether Sec34p
was required for tethering as well. We thus employed two
in vitro assays that, together, are able to distinguish the
stages of budding, tethering, and fusion in ER to Golgi
complex transport (Barlowe, 1997; Cao et al., 1998).
In the first assay (Fig. 6 a), overall ER to Golgi complex
transport is measured in semi-intact cells incubated with a
mixture of purified protein components that drive all the
stages of transport: vesicle formation from the ER is supported by the addition of COPII proteins, efficient vesicle
tethering requires added Uso1p, and vesicle fusion requires a protein complex termed LMA1. Productive transport is monitored by following the addition of a1,6-mannose residues to gp-a-factor, an event that occurs in the
cis-Golgi complex. Generation of this transport system
from conditional mutants has shown that the system also
requires the activities of several peripheral and integral
membrane proteins including Ypt1p, Sec35p, and the
SNAREs (Cao et al., 1998; VanRheenen et al., 1998). Although there is no requirement for exogenous Sec34p in
the system, Sec34p may be supplied to the assay by peripheral association with membranes of the semi-intact cells.
Therefore, to test for a requirement for Sec34p, we generated the in vitro system from the sec34-2 strain. In wildtype or sec34-2 mutant cells at 238C, movement of gpa-factor from the ER to the Golgi complex in this in vitro
system proceeds with a similar efficiency (Fig. 6 a). In contrast, at 298C in sec34-2 semi-intact cells, this process is
very inefficient relative to wild-type, indicating that sec34-2
is defective for overall ER to Golgi transport in vitro.
The second assay we employed examined the functionality of the vesicle budding and vesicle tethering steps in
the sec34-2 mutant (Fig. 6 b). In this assay, release of vesicles from semi-intact cells is detected by the appearance of
protease-protected gp-a-factor in a low-speed supernatant
at the end of the reaction. Vesicles were efficiently generated upon addition of COPII components to wild-type or
sec34-2 semi-intact cells at 23 or 298C (Fig. 6 b). These
data indicate that Sec34p is not required for ER-derived
vesicle budding. Because addition of Uso1p significantly
reduced vesicle release, vesicle tethering was also func-
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Figure 6. Sec34p is required for the tethering phase of ER to
Golgi complex transport in vitro. a, Sec34p is required for in vitro
transport. Semi-intact cells isolated from wild-type (left) and
sec34-2 (right) strains were incubated at 23 or 298C for 60 min.
Reactions contained an ATP regeneration system alone (No addition, solid bars) or COPII, Uso1p, and LMA1 (Reconstituted,
open bars). a1,6-mannose-modified forms of 35S-gp-a-factor
were immunoprecipitated with a1,6-mannose-specific antibodies
and the percent transport reflects the amount of total 35S-gpa-factor (determined from precipitation with Concanavalin A)
that obtained Golgi complex-specific outer chain modifications.
b, Sec35p is required for vesicle tethering. Semi-intact cells prepared from wild-type (left) and sec34-2 (right) strains were incubated at 23 or 298C for 30 min. Reactions contained an ATP regenerating system alone (No addition, solid bars), COPII (open
bars), or COPII and Uso1p (hatched bars). Freely diffusible vesicles containing 35S-gp-a-factor were separated from semi-intact
membranes by centrifugation at 18,000 g for 3 min. The percent
diffusible vesicles reflects the fraction of protease-protected,
Concanavalin A-precipitable 35S-gp-a-factor present in the supernatant.

tional in the semi-intact wild-type cells at 23 or 298C, as
well as in sec34-2 semi-intact cells at 238C. In contrast,
when Uso1p was added to the sec34-2-derived system at
the restrictive temperature of 298C, vesicle release was
only slightly diminished (Fig. 6 b). This result indicates
that the sec34-2 mutant cannot efficiently tether ERderived vesicles to the yeast Golgi complex.

sec34 and sec35 Display a Synthetic Lethal Interaction
The similar genetic interactions of SEC34 and SEC35 with
genes involved in the docking stage of vesicular transport,
taken together with their genetic interaction with one another, and with the finding that both proteins function in
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vesicle tethering, lead us to examine whether mutations in
the two genes would display a synthetic lethal interaction.
To do this, we generated a diploid strain heterozygous for
both the sec34-2 and sec35-1 alleles and subjected it to tetrad analysis. Although both the sec34-2 and sec35-1 haploid strains are permissive for growth at both 21 and 308C,
tetrads from the diploid sec34-2/SEC34 SEC35/sec35-1
strain yielded numerous inviable colonies at either temperature (Fig. 7 a). After incubation of the segregants for
long periods of time, a small proportion of those previously characterized as inviable would form visible
microcolonies. Since this phenotype was variable, we hypothesize that the microcolonies result from either the
appearance of spontaneous suppressors of the inviability
or from background mutations in the strain. Examination
of the viable segregants in each tetrad for temperature
sensitivity revealed a pattern in which the inviable segregants are predicted to be those containing both the
sec34-2 and the sec35-1 alleles. To confirm this prediction,
the diploid strain was transformed with low-copy plasmids
bearing either SEC34 or SEC35 before tetrad dissection.
The presence of either plasmid lead to a greater proportion of viable segregants than was observed for the untransformed strain, concurrent with the appearance of segregants that were sensitive to the drug 5-fluoro-orotic acid,
which is toxic to cells that must maintain the plasmid to
survive (data not shown). Therefore, the sec34-2 and
sec35-1 alleles display a synthetic lethal phenotype, which
can be complemented by the presence of either gene on a
plasmid.

Sec34p and Sec35p Interact in the Two-hybrid Assay
In many cases, synthetic lethality between alleles of two
genes involved in secretion indicates that their gene products are involved in the same stage of secretion (Kaiser
and Schekman, 1990). Furthermore, such genetic interactions can also be indicative of a physical interaction of the
proteins encoded by those genes, as is the case for mutations in the a and b subunits of tubulin (Huffaker et al.,
1987). Therefore, we investigated whether Sec34p and
Sec35p physically interact using the two-hybrid system
(Fields and Song, 1989). A strain in which transcription of
both the ADE2 and HIS3 genes is under the control of the
Gal4p transcriptional activator (James et al., 1996) was
transformed with plasmids expressing either the Gal4pBD or Gal4p-AD, either alone or fused to Sec34p or
Sec35p. Activation of transcription of the ADE2 and HIS3
genes was assessed by the ability of the strain to grow on
media lacking adenine or histidine, respectively. As an example of a positive two-hybrid interaction, coexpression of
p53 fused to the Gal4p-BD and the large T-antigen fused
to the Gal4p-AD was demonstrated to activate both reporter genes (Fig. 7 b), as has been described previously
(Iwabuchi et al., 1993). Strains expressing either the
Sec34p-Gal4p-BD or the Sec35p-Gal4p-AD fusion protein were unable to grow on either media. However, when
Sec34p-Gal4p-BD was expressed along with the Sec35pGal4p-AD, the strain grew well on media lacking either
adenine or histidine (Fig. 7 b), indicating that the interaction of Sec34p with Sec35p was able to localize the Gal4pAD to the promoters of these genes, activating transcrip-
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Figure 7. Genetic and biochemical interactions between Sec34p
and Sec35p. a, The sec34-2 and sec35-1 alleles display a synthetic
lethal interaction. A diploid strain resulting from the mating of
GWY95 (sec34-2) to GWY93 (sec35-1) was sporulated, dissected,
and incubated on YPD at 308C for three days. Ten representative
tetrads are shown. b, Interaction of Sec34p and Sec35p by twohybrid analysis. A two-hybrid strain (PJ69-4A) was transformed
with plasmids expressing fusion proteins with the Gal4p-BD (either Gal4p-BD-Sec34p, pSV37; Gal4p-BD-Sec35p, pSV34; or
Gal4p-BD-p53, pVA3) and the Gal4p-AD (either Gal4p-ADSec34p, pSV35; Gal4p-AD-Sec35p, pSV36; or Gal4p-AD-large
T-antigen, pTD3) or with plasmids expressing the BD or AD
alone (Gal4p-BD, pGAD424 and Gal4p-AD, pAS2, indicated by
--), as shown on the left of the figure. Strains were grown to stationary phase in SC-Trp-Leu and analyzed as described in Fig. 3
with the following exceptions. The diluted samples were spotted
onto either SC lacking adenine, leucine, and tryptophan (SCAde), or SC lacking histidine, leucine, and tryptophan, but containing 2.5 mM 3-aminotriazole (SC-His), and the plates were incubated at 308C for three days.

tion. When the converse experiment was completed, in
which Sec35p was fused to the Gal4p-BD and Sec34p was
fused to the Gal4p-AD, expression of the ADE2 and HIS3
genes was also observed only when both fusion proteins
were expressed. Thus, Sec34p and Sec35p interact.

Sec34p and Sec35p Are Components of a Large
Protein Complex
To characterize the interaction of Sec34p and Sec35p further, we employed immunoblotting to monitor the behavior of these proteins during fractionation of yeast cytosol.
Sec34p and Sec35p coprecipitated in 35% saturated ammonium sulfate and cofractionated precisely by DEAE
anion exchange chromatography (data not shown). An aliquot of the Sec34p/Sec35p anion exchange pool was then
subjected to size exclusion chromatography on Superose 6
(Fig. 8 a), and once again, Sec34p and Sec35p precisely
cofractionate. Interestingly, they elute from the column
slightly before thyroglobulin, a 669-kD globular protein.
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These results are consistent with Sec34p and Sec35p existing in a large protein complex with a mass of up to z750 kD.
A small amount of monomeric Sec35p is also evident upon
gel filtration, suggesting either that some Sec35p has dissociated from the complex or that a cytosolic pool of monomeric Sec35p exists. No such monomeric Sec34p has been
detected in cytosolic fractions. To further purify the
Sec34p/Sec35p complex, the remainder of the DEAE anion exchange pool was subjected to several sequential
chromatographic steps (see Materials and Methods), including Sephacryl S-300 gel filtration (data not shown),
MonoQ anion exchange (Fig. 8 b), MonoS cation exchange (Fig. 8 c), Superose 6 gel filtration (data not
shown), and ceramic hydroxyapatite (Fig. 8 d). Once
again, Sec34p and Sec35p precisely comigrate through
each step, strongly indicating that Sec34p and Sec35p are
present in a large protein complex.

Discussion
Much effort has been extended towards gaining an understanding of the mechanism of transport vesicle docking in
the secretory pathway. Several families of proteins are involved in this event, including the rab family of small
GTP-binding proteins and the SNARE family of integral
membrane proteins. Recently, another class of proteins
has been described, the tethering factors. Although these
proteins do not display homology with one another and
thus do not define a family, they share a similar function in
docking, that of connecting the vesicle to the target compartment before the interaction of v- and t-SNAREs (for
reviews see Pfeffer, 1999; Waters and Pfeffer, 1999). The
docking event can therefore be separated into two distinct
substages, tethering and SNARE-dependent docking.
A recent genetic screen identified temperature-sensitive
alleles of two genes, SEC34 and SEC35, that, when incubated at the restrictive temperature, are defective in ER to
Golgi complex transport and accumulate large numbers of
vesicles (Wuestehube et al., 1996). Mutant alleles of these
genes are also able to be suppressed by the dominant allele of SLY1, SLY1-20, a trait shared with all previously
characterized ER to Golgi complex tethering factors (Sapperstein et al., 1996; Cao et al., 1998; VanRheenen et al.,
1998). Based on these data, we hypothesized that SEC34
and SEC35 might be involved in tethering, and this was
demonstrated to be the case for SEC35 by the discovery
that this gene both displayed a genetic interaction with
genes involved in tethering and is required in this process
as revealed by an in vitro assay (VanRheenen et al., 1998).
We therefore investigated whether Sec34p functions in
tethering as well.

Figure 8. Sec34p and Sec35p are components of a large protein
complex. a, Sec34p and Sec35p cofractionate by Superose 6 sizeexclusion chromatography. Pooled fractions from a DEAE anion
exchange column containing Sec34p and Sec35p were fractionated by size-exclusion chromatography. Proteins contained in the
load (L), as well as the column, fractions were separated by SDS11%PAGE and immunoblotted with antibodies against Sec34p
or Sec35p, as indicated. The immunoreactive protein marked
with an asterisk (*) is unrelated to Sec34p (see Fig. 5 a). The elution position of 25, 67, 232, and 669 kD protein standards, as well
as the location of the void volume, is indicated at the top. b–d,
Sec34p and Sec35p cofractionate through sequential chromatographic steps. b, Sec34p and Sec35p cofractionate by MonoQ anion exchange chromatography. The remainder of the DEAE anion exchange pool containing Sec34p and Sec35p was subjected
to Sephacryl S-300 gel filtration chromatography, and the pooled
Sec34p- and Sec35p-containing fractions were loaded onto a
MonoQ anion exchange column and eluted with a linear KCl gradient. Proteins contained in the load (L), flow-through fractions
(FT), and every second gradient elution fraction were analyzed
as described in a. c, Sec34p and Sec35p cofractionate by MonoS
cation exchange chromatography. Fractions 8–11 from the
MonoQ step described in b were loaded onto a MonoS anion exchange column and eluted with a linear KCl gradient. Proteins
contained in the load (L), flow-through fractions (FT), and every
second gradient elution fraction were analyzed as described in a.
d, Sec34p and Sec35p cofractionate on ceramic hydroxyapatite.
Fractions 4–7 from the MonoS chromatographic step described

in c were subjected to Superose 6 gel filtration chromatography
and the Sec34p- and Sec35-containing fractions were pooled,
loaded onto a ceramic hydroxyapatite column, and eluted with a
linear potassium phosphate (PO423) gradient. Proteins in the
load (L), flow-through (FT), and every third gradient elution
fraction were analyzed as described in a. The apparent difference
in Sec34p and Sec35p abundance in fractions 10 and 13 is likely
an artifact of chemiluminescent detection because reanalysis of
every fraction in this region yields precise comigration and relative abundance (data not shown).
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To begin our study of SEC34, we cloned the gene by
complementation of the temperature-sensitive phenotype
of a strain bearing the sec34-2 mutation. SEC34 was discovered to be a novel gene encoding a protein with a predicted molecular weight of 93 kD. Deletion of SEC34 in a
haploid strain resulted in a severe growth defect, and thus
SEC34 is essential for wild-type growth rates, although not
for viability.
To investigate the genetic interactions of SEC34 we employed multicopy suppressor analysis. The best suppression of the sec34-2 temperature-sensitive growth defect was
conferred by overexpression of Ypt1p, the rab required in
ER to Golgi complex transport, or by expression of Sly120p, the dominant form of the t-SNARE–associated factor, Sly1p. Suppression of the SEC34 deletion strain allowed us to order the action of Sec34p with respect to
Ypt1p and Sly1p. Since either YPT1 or SLY1-20 can suppress both mutations in, and a deletion of, SEC34, yet
overexpression of SEC34 cannot suppress mutations in either YPT1 or SLY1, we hypothesize that Ypt1p and Sly1p
function downstream of Sec34p.
Weaker suppression of the sec34-2 mutation was observed upon overexpression of the tethering factor Uso1p,
or the v-SNAREs Sec22p, Bet1p, or Ykt6p. The suppression of sec34-2 by the v-SNAREs may be through
mass action, in which vesicles containing supernumerary
v-SNAREs are able to compensate for a deficiency in tethering, albeit with a very low efficiency. This phenomena
has been observed previously for mutations in the tethering factors Uso1p (Sapperstein et al., 1996) and Sec35p
(VanRheenen et al., 1998), as well as components of the
putative tethering complex TRAPP (Jiang et al., 1998). Interestingly, no suppression of the sec34-2 mutation was
observed upon overexpression of either the v-SNARE
Bos1p or the cis-Golgi complex t-SNARE Sed5p. Overexpression of Bos1p was also unable to suppress a temperature-sensitive growth defect of the sec35-1 strain (VanRheenen et al., 1998) or the inviability of the uso1D strain
(Sapperstein et al., 1996). This lack of suppression could
result from inefficient expression of the gene or may indicate a functional difference between Bos1p and the other
v-SNAREs that mediate the ER to Golgi complex transport step. The lack of suppression of the sec34-2 mutant
strain by high-copy expression of Sed5p was not unexpected, because it has been demonstrated that overexpression of this t-SNARE is toxic to cells (Hardwick and Pelham, 1992).
Biochemical analysis of the Sec34 protein reveals that
it is a peripheral membrane protein. Although a small
amount of the protein is soluble, the remainder partitions
between the P10 and P175 fractions, similar to the Golgi
protein Sed5p; it is possible, therefore, that Sec34p is associated with the Golgi complex. Due to the association of
Sec34p with membranes, we used semi-intact cells made
from the sec34-2 strain to test the requirement for Sec34p
in tethering through an assay that reconstitutes ER to
Golgi complex transport. These semi-intact cells were
demonstrated to be able to bud vesicles from the ER, but
these vesicles failed to efficiently tether to the Golgi complex at the restrictive temperature, indicating that Sec34p
is required for the tethering of ER-derived vesicles to the
cis-Golgi complex. Since cytosolic proteins are removed

from the sec34-2 semi-intact cells, the membrane-associated pool of Sec34-2p is most likely the source of the tethering defect. In addition, since the membranes involved in
tethering are restricted to those of the vesicle and the cisGolgi complex, Sec34p is most likely associating with one,
or both, of these membranes.
SEC34 was found to display two interesting genetic interactions with the tethering factor gene SEC35. First,
multicopy SEC34 weakly suppresses a temperature-sensitive allele of SEC35. Since overexpression of SEC34 cannot suppress the cold-sensitive lethality of the sec35D
strain, Sec34p is able to assist a handicapped allele of
SEC35, but cannot replace its function. Second, the sec34-2
and sec35-1 alleles display a synthetic lethal interaction.
Although strains bearing either allele alone are permissive
for growth at 23 and 308C, a haploid strain containing both
the sec34-2 and sec35-1 alleles is inviable at either temperature. This synthetic phenotype is more severe than the
conditional synthetic lethality of the sec35-1 allele in combination with a mutant allele of either YPT1 or USO1, in
which the double mutants are viable at 238C, but not at
308C (VanRheenen et al., 1998). This finding suggests a
close functional interaction of the Sec34 and Sec35 proteins.
Based on these results, we investigated whether Sec34p
and Sec35p could physically interact through the twohybrid assay. Indeed, Sec34p and Sec35p were found to
interact. The interaction between the two proteins may explain the ability of multicopy SEC34 to suppress the
sec35-1 allele, but not the sec35D allele: increased levels of
Sec34p could stabilize a defective form of Sec35p but
would be ineffectual in the absence of Sec35p, especially if
the interaction of the two proteins is essential to their function in tethering. To further explore the interaction of
Sec34p and Sec35p we examined the behavior of the soluble pool of these proteins through several chromatographic
steps. The proteins cofractionated through ammonium sulfate precipitation and anion exchange, cation exchange, ceramic hydroxyapatite, and size exclusion chromatographic
steps, providing strong evidence that the two proteins are
in a complex with one another. Intriguingly, the Sec34p/
Sec35p complex appears quite large, with an estimated molecular weight (if globular) of z750 kD. This size, which is
larger than the combined molecular weights of the two proteins (124 kD), suggests several possibilities for the structure
of the complex. First, the complex could be homodimeric,
containing one molecule of each protein, but highly elongated such that it migrates rapidly through a size exclusion
column. We consider this unlikely because the sequences of
Sec34p and Sec35p lack motifs (such as coiled-coil domains)
that would be indicative of an elongated structure. Second,
the complex could contain two or more molecules of at least
one protein, resulting in a more massive structure. Finally,
the complex could be multimeric, containing heretofore unidentified component(s) in addition to Sec34p and Sec35p.
We are currently purifying the Sec34p/Sec35p complex to
address this issue and identify any additional components. It
appears, however, that Uso1p is unlikely to be a component
of the Sec34p/Sec35p complex since immunoblotting fractions from the purification with an antibody against this protein revealed that Uso1p did not comigrate with Sec34p and
Sec35p (data not shown).

The Journal of Cell Biology, Volume 147, 1999

740

The 750-kD complex containing Sec34p and Sec35p is
reminiscent of the TRAPP complex, which migrates at
z800 kD by size exclusion chromatography (Sacher et al.,
1998). However, two pieces of data indicate that the
TRAPP complex is distinct from the Sec34p/Sec35p complex. First, the identities of the low molecular weight
members of the TRAPP complex have been elucidated,
and none corresponds to Sec35p, whose mobility on SDSPAGE was within the range of the proteins that have been
sequenced (Sacher et al., 1998). In addition, the known
members of the TRAPP complex display genetic interactions with one another (Jiang et al., 1998; Sacher et al.,
1998), yet no interaction was discerned between the gene
encoding the TRAPP component Bet3p and either SEC34
or SEC35 (this work and VanRheenen et al., 1998).
Since many secretory factors are evolutionarily conserved, we explored whether the components of the
Sec34p/Sec35p complex were conserved in higher eukaryotes. The genome of the nematode C. elegans was discovered to contain a protein designated Y71F9A 290.A that is
very similar to Sec34p. However, the C. elegans protein is
z50% the size of Sec34p and therefore may not be a true
ortholog. We also discovered a C. elegans protein with
moderate homology to Sec35p (22% identical and 33%
similar), designated C35A5.6. While the similarity is not
high, the proteins are similar in size (C35A5.6 is comprised
of 273 amino acid residues, whereas Sec35p is comprised
of 275 amino acid residues), and thus, this C. elegans protein is a putative ortholog of Sec35p. Searches of GenBank
for additional homologs of these proteins did not reveal
additional Sec35p homologs, but several human ESTs
were discovered with a high degree of similarity to Sec34p.
Interestingly, the sequences contained on these ESTs were
homologous to Sec34p over only a portion of the analyzed
region of the putative human protein, and thus the protein
may contain a Sec34p-like domain and may not be a true
Sec34p ortholog. These data indicate that there may be
orthologs of the Sec34p/Sec35p complex in higher organisms, but functional experiments will be required to unambiguously address this point. Finally, a putative ortholog of
Sec34p was discovered in the genome of S. pombe. No
paralogs of either Sec34p or Sec35p exist in S. cerevisiae,
and thus these proteins do not define a family of related
proteins.
Finally, we describe the identification and characterization of a gene designated RUD3 that displays a genetic interaction with SEC34. RUD3, which encodes a novel nonessential protein with a predicted molecular weight of 56 kD,
was originally identified in a screen for multicopy suppressors of a temperature-sensitive allele of the tethering factor, USO1 (Sapperstein et al., 1996; Sapperstein, 1997),
and is also able to suppress the temperature-sensitive
growth defect of the sec34-2 strain. Interestingly, RUD3 is
unable to suppress mutations in other ER to Golgi complex docking factors such as Sec35p, Ypt1p, Sec22p,
Bet1p, or Bos1p, and thus the suppression is specific to
mutant alleles of SEC34 and USO1. Overexpression of
RUD3 can weakly suppress the inviability of the uso1D
strain (data not shown). Taken together, these data suggest that Rud3p either acts at, or downstream of, the tethering stage of ER to Golgi complex transport. Rud3p does
not appear to be a component of the Sec34p/Sec35p com-

VanRheenen et al. Sec34p/Sec35p Complex and Vesicle Tethering

plex since the majority of the protein fractionates away
from the complex during its purification (data not shown).
In summary, we describe the characterization of a novel
secretory factor, Sec34p, and its role in tethering of
ER-derived vesicles to the cis-Golgi complex. Unlike the
SNAREs and rabs, the tethering factors described thus far
at different intracellular transport steps are not members
of a protein family. Nevertheless, they do share structural
similarity, since they are either elongated or present in a
large multimeric complex (Pfeffer, 1999; Waters and Pfeffer, 1999). The large size may be related to the requirement for the tethering factors to span the distance between the vesicle and the target compartment, before
trans-SNARE complex formation. Interestingly, three
factors meet this criteria in the yeast ER to Golgi complex transport step: the extended homodimer Uso1p, the
TRAPP complex, and the Sec34p/Sec35p complex. It will
be very exciting to discover in the future how these large
protein complexes function to secure a vesicle to its target
membrane, and whether their function is more complex
than simply connecting vesicle and target membranes.
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